202 related articles for article (PubMed ID: 33913372)
1. PANX2 and brain lower grade glioma genesis: A bioinformatic analysis.
Xu X; Hao Y; Xiong S; He Z
Sci Prog; 2021; 104(2):368504211011836. PubMed ID: 33913372
[TBL] [Abstract][Full Text] [Related]
2. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
3. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
4. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
5. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
[TBL] [Abstract][Full Text] [Related]
6. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
7. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
Han Z; Jia J; Lv Y; Wang R; Cao K
Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
[TBL] [Abstract][Full Text] [Related]
10. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
11. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma.
Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ
Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065
[TBL] [Abstract][Full Text] [Related]
12. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
[TBL] [Abstract][Full Text] [Related]
13. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Su X; Li H; Chen S; Qin C
Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
[TBL] [Abstract][Full Text] [Related]
14. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The Cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract][Full Text] [Related]
15.
Ma W; Zhang K; Bao Z; Jiang T; Zhang Y
Front Immunol; 2021; 12():659659. PubMed ID: 33936093
[TBL] [Abstract][Full Text] [Related]
16. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
[TBL] [Abstract][Full Text] [Related]
17. Pannexin2 as a novel growth regulator in C6 glioma cells.
Lai CP; Bechberger JF; Naus CC
Oncogene; 2009 Dec; 28(49):4402-8. PubMed ID: 19749789
[TBL] [Abstract][Full Text] [Related]
18. miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC.
Zhou DD; Li HL; Liu W; Zhang LP; Zheng Q; Bai J; Hu YQ; Yin CG; Lv SJ; Zhang BG
Biomed Res Int; 2021; 2021():8928509. PubMed ID: 33628829
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Potential of Secreted Modular Calcium-Binding Protein 1 in Low-Grade Glioma.
Wang J; Xia S; Zhao J; Gong C; Xi Q; Sun W
Front Mol Biosci; 2021; 8():666623. PubMed ID: 34869577
[No Abstract] [Full Text] [Related]
20. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data.
Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL
J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
